25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IL3 (Integra LifeSciences Holdings Corporation) Stock Analysis
Buy, Hold or Sell?

Let's analyze Integra LifeSciences Holdings Corporation together

I guess you are interested in Integra LifeSciences Holdings Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Integra LifeSciences Holdings Corporation’s Financial Insights
  • 📈 Technical Analysis (TA) – Integra LifeSciences Holdings Corporation’s Price Targets

I'm going to help you getting a better view of Integra LifeSciences Holdings Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Integra LifeSciences Holdings Corporation

I send you an email if I find something interesting about Integra LifeSciences Holdings Corporation.

1. Quick Overview

1.1. Quick analysis of Integra LifeSciences Holdings Corporation (30 sec.)










1.2. What can you expect buying and holding a share of Integra LifeSciences Holdings Corporation? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€17.81
Expected worth in 1 year
€17.54
How sure are you?
72.7%

+ What do you gain per year?

Total Gains per Share
€-0.28
Return On Investment
-2.5%

For what price can you sell your share?

Current Price per Share
€11.20
Expected price per share
€0 - €20.20
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Integra LifeSciences Holdings Corporation (5 min.)




Live pricePrice per Share (EOD)
€11.20
Intrinsic Value Per Share
€-29.32 - €-35.84
Total Value Per Share
€-11.51 - €-18.03

2.2. Growth of Integra LifeSciences Holdings Corporation (5 min.)




Is Integra LifeSciences Holdings Corporation growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5b$1.6b-$81.5m-5.3%

How much money is Integra LifeSciences Holdings Corporation making?

Current yearPrevious yearGrowGrow %
Making money-$1.7m$16.9m-$18.6m-1,075.7%
Net Profit Margin-0.6%4.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Integra LifeSciences Holdings Corporation (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#298 / 299

Most Revenue
#40 / 299

Most Profit
#226 / 299

Most Efficient
#130 / 299
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Integra LifeSciences Holdings Corporation?

Welcome investor! Integra LifeSciences Holdings Corporation's management wants to use your money to grow the business. In return you get a share of Integra LifeSciences Holdings Corporation.

First you should know what it really means to hold a share of Integra LifeSciences Holdings Corporation. And how you can make/lose money.

Speculation

The Price per Share of Integra LifeSciences Holdings Corporation is €11.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Integra LifeSciences Holdings Corporation.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Integra LifeSciences Holdings Corporation, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €17.81. Based on the TTM, the Book Value Change Per Share is €-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Integra LifeSciences Holdings Corporation.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.252.2%-0.02-0.2%0.211.9%0.242.2%0.332.9%0.282.5%
Usd Book Value Change Per Share0.312.7%-0.08-0.7%-0.31-2.8%0.010.1%0.181.6%0.615.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.312.7%-0.08-0.7%-0.31-2.8%0.010.1%0.181.6%0.615.4%
Usd Price Per Share23.80-26.92-46.23-43.91-49.43-52.04-
Price to Earnings Ratio23.66--67.83-84.53-15.03--109.80--35.36-
Price-to-Total Gains Ratio77.63--465.27-49.00--128.98--20.98-32.33-
Price to Book Ratio1.19-1.35-2.27-2.17-2.59-3.12-
Price-to-Total Gains Ratio77.63--465.27-49.00--128.98--20.98-32.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.57536
Number of shares79
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.080.18
Usd Total Gains Per Share-0.080.18
Gains per Quarter (79 shares)-6.1213.84
Gains per Year (79 shares)-24.4755.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-24-3405545
20-49-580111100
30-73-820166155
40-98-1060221210
50-122-1300277265
60-147-1540332320
70-171-1780388375
80-196-2020443430
90-220-2260498485
100-245-2500554540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%9.03.00.075.0%16.04.00.080.0%28.05.00.084.8%28.05.00.084.8%
Book Value Change Per Share1.03.00.025.0%6.06.00.050.0%13.07.00.065.0%24.09.00.072.7%24.09.00.072.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.033.00.0%0.00.033.00.0%
Total Gains per Share1.03.00.025.0%6.06.00.050.0%13.07.00.065.0%24.09.00.072.7%24.09.00.072.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Integra LifeSciences Holdings Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.273-0.069+125%-0.280+202%0.008+3173%0.156+75%0.540-49%
Book Value Per Share--17.81117.756+0%18.123-2%18.010-1%17.139+4%15.634+14%
Current Ratio--1.1732.612-55%3.192-63%3.165-63%3.335-65%3.254-64%
Debt To Asset Ratio--0.6170.6190%0.566+9%0.578+7%0.581+6%0.586+5%
Debt To Equity Ratio--1.6131.623-1%1.307+23%1.385+16%1.396+16%1.436+12%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---581307052.800-372382103.600-36%1409198399.400-141%1179716457.800-149%1693210937.775-134%1957674652.635-130%
Eps--0.224-0.020+109%0.189+19%0.217+3%0.290-23%0.246-9%
Ev To Sales Ratio---0.369-0.255-31%1.029-136%0.860-143%1.270-129%1.581-123%
Free Cash Flow Per Share--0.1290.043+199%0.242-47%0.288-55%0.418-69%0.418-69%
Free Cash Flow To Equity Per Share--0.0470.710-93%-0.389+936%0.076-39%0.303-85%0.303-85%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---35.837----------
Intrinsic Value_10Y_min---29.321----------
Intrinsic Value_1Y_max--0.467----------
Intrinsic Value_1Y_min--0.461----------
Intrinsic Value_3Y_max---1.690----------
Intrinsic Value_3Y_min---1.551----------
Intrinsic Value_5Y_max---7.576----------
Intrinsic Value_5Y_min---6.766----------
Market Cap865198924.800-89%1637697964.8001866290959.600-12%3304894725.000-50%3174938653.200-48%3642492470.295-55%3740493783.035-56%
Net Profit Margin--0.044-0.006+113%0.044+0%0.051-14%0.070-38%0.061-28%
Operating Margin----0%0.040-100%0.076-100%0.119-100%0.129-100%
Operating Ratio--1.3571.437-6%1.354+0%1.338+1%1.310+4%1.224+11%
Pb Ratio0.629-89%1.1901.348-12%2.271-48%2.168-45%2.589-54%3.117-62%
Pe Ratio12.499-89%23.659-67.826+387%84.531-72%15.029+57%-109.801+564%-35.363+249%
Price Per Share11.200-89%21.20023.975-12%41.175-49%39.108-46%44.020-52%46.347-54%
Price To Free Cash Flow Ratio21.715-89%41.103619.734-93%49.127-16%231.450-82%80.437-49%48.750-16%
Price To Total Gains Ratio41.012-89%77.630-465.272+699%49.004+58%-128.980+266%-20.981+127%32.327+140%
Quick Ratio--0.3250.693-53%0.823-61%0.781-58%0.773-58%0.840-61%
Return On Assets--0.0050.000+109%0.005+7%0.005-10%0.007-34%0.007-28%
Return On Equity--0.013-0.001+109%0.010+20%0.012+6%0.017-26%0.016-21%
Total Gains Per Share--0.273-0.069+125%-0.280+202%0.008+3173%0.156+75%0.540-49%
Usd Book Value--1544879957.9141549352299.8140%1630878438.862-5%1627007691.180-5%1577276768.855-2%1415292665.674+9%
Usd Book Value Change Per Share--0.307-0.077+125%-0.314+202%0.009+3173%0.175+75%0.606-49%
Usd Book Value Per Share--19.99819.937+0%20.349-2%20.221-1%19.244+4%17.554+14%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---652691558.884-418110625.922-36%1582247962.846-141%1324585638.818-149%1901137240.934-134%2198077099.979-130%
Usd Eps--0.252-0.022+109%0.212+19%0.243+3%0.325-23%0.277-9%
Usd Free Cash Flow--11184103.9093751778.488+198%21692882.692-48%26592197.363-58%39233190.682-71%23777691.322-53%
Usd Free Cash Flow Per Share--0.1450.048+199%0.272-47%0.324-55%0.470-69%0.470-69%
Usd Free Cash Flow To Equity Per Share--0.0520.797-93%-0.437+936%0.085-39%0.340-85%0.340-85%
Usd Market Cap971445352.765-89%1838807274.8772095471489.439-12%3710735797.230-50%3564821119.813-48%4089790545.647-55%4199826419.592-56%
Usd Price Per Share12.575-89%23.80326.919-12%46.231-49%43.911-46%49.426-52%52.038-54%
Usd Profit--19429968.667-1735300.649+109%16930865.802+15%20107126.652-3%27208704.387-29%22670129.637-14%
Usd Revenue--442531407.804402527516.693+10%385293479.395+15%392378894.648+13%381105413.883+16%365298740.307+21%
Usd Total Gains Per Share--0.307-0.077+125%-0.314+202%0.009+3173%0.175+75%0.606-49%
 EOD+4 -4MRQTTM+23 -12YOY+18 -183Y+12 -245Y+11 -2510Y+8 -28

3.3 Fundamental Score

Let's check the fundamental score of Integra LifeSciences Holdings Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.499
Price to Book Ratio (EOD)Between0-10.629
Net Profit Margin (MRQ)Greater than00.044
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.325
Current Ratio (MRQ)Greater than11.173
Debt to Asset Ratio (MRQ)Less than10.617
Debt to Equity Ratio (MRQ)Less than11.613
Return on Equity (MRQ)Greater than0.150.013
Return on Assets (MRQ)Greater than0.050.005
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Integra LifeSciences Holdings Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.317
Ma 20Greater thanMa 5014.610
Ma 50Greater thanMa 10018.272
Ma 100Greater thanMa 20020.598
OpenGreater thanClose11.200
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Fundamental data was last updated by Penke on 2025-05-02 17:33:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Integra LifeSciences Holdings Corporation earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Integra LifeSciences Holdings Corporation to the Medical Devices industry mean.
  • A Net Profit Margin of 4.4% means that €0.04 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 4.4%. The company is making a profit. +1
  • The TTM is -0.6%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ4.4%TTM-0.6%+5.0%
TTM-0.6%YOY4.4%-5.0%
TTM-0.6%5Y7.0%-7.6%
5Y7.0%10Y6.1%+0.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4%-4.7%+9.1%
TTM-0.6%-10.5%+9.9%
YOY4.4%-14.9%+19.3%
3Y5.1%-13.6%+18.7%
5Y7.0%-11.9%+18.9%
10Y6.1%-9.6%+15.7%
4.3.1.2. Return on Assets

Shows how efficient Integra LifeSciences Holdings Corporation is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Integra LifeSciences Holdings Corporation to the Medical Devices industry mean.
  • 0.5% Return on Assets means that Integra LifeSciences Holdings Corporation generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.0%+0.5%
TTM0.0%YOY0.5%-0.5%
TTM0.0%5Y0.7%-0.8%
5Y0.7%10Y0.7%+0.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%-2.4%+2.9%
TTM0.0%-2.9%+2.9%
YOY0.5%-3.7%+4.2%
3Y0.5%-3.1%+3.6%
5Y0.7%-2.7%+3.4%
10Y0.7%-3.1%+3.8%
4.3.1.3. Return on Equity

Shows how efficient Integra LifeSciences Holdings Corporation is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Integra LifeSciences Holdings Corporation to the Medical Devices industry mean.
  • 1.3% Return on Equity means Integra LifeSciences Holdings Corporation generated €0.01 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 1.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.3%TTM-0.1%+1.4%
TTM-0.1%YOY1.0%-1.2%
TTM-0.1%5Y1.7%-1.8%
5Y1.7%10Y1.6%+0.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%-1.8%+3.1%
TTM-0.1%-4.8%+4.7%
YOY1.0%-4.1%+5.1%
3Y1.2%-4.4%+5.6%
5Y1.7%-4.2%+5.9%
10Y1.6%-5.5%+7.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Integra LifeSciences Holdings Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Integra LifeSciences Holdings Corporation is operating .

  • Measures how much profit Integra LifeSciences Holdings Corporation makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Integra LifeSciences Holdings Corporation to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY4.0%-4.0%
TTM-5Y11.9%-11.9%
5Y11.9%10Y12.9%-0.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.5%+14.5%
TTM--14.0%+14.0%
YOY4.0%-15.5%+19.5%
3Y7.6%-11.7%+19.3%
5Y11.9%-11.4%+23.3%
10Y12.9%-11.1%+24.0%
4.3.2.2. Operating Ratio

Measures how efficient Integra LifeSciences Holdings Corporation is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.36 means that the operating costs are €1.36 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 1.357. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.437. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.357TTM1.437-0.080
TTM1.437YOY1.354+0.083
TTM1.4375Y1.310+0.127
5Y1.31010Y1.224+0.086
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3571.321+0.036
TTM1.4371.309+0.128
YOY1.3541.260+0.094
3Y1.3381.301+0.037
5Y1.3101.325-0.015
10Y1.2241.304-0.080
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Integra LifeSciences Holdings Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Integra LifeSciences Holdings Corporation is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.17 means the company has €1.17 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 1.173. The company is just able to pay all its short-term debts.
  • The TTM is 2.612. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.173TTM2.612-1.439
TTM2.612YOY3.192-0.580
TTM2.6125Y3.335-0.723
5Y3.33510Y3.254+0.081
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1732.598-1.425
TTM2.6122.674-0.062
YOY3.1922.736+0.456
3Y3.1653.037+0.128
5Y3.3353.506-0.171
10Y3.2543.391-0.137
4.4.3.2. Quick Ratio

Measures if Integra LifeSciences Holdings Corporation is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Integra LifeSciences Holdings Corporation to the Medical Devices industry mean.
  • A Quick Ratio of 0.32 means the company can pay off €0.32 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 0.325. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.693. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.325TTM0.693-0.368
TTM0.693YOY0.823-0.130
TTM0.6935Y0.773-0.080
5Y0.77310Y0.840-0.067
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3251.351-1.026
TTM0.6931.456-0.763
YOY0.8231.752-0.929
3Y0.7811.914-1.133
5Y0.7732.251-1.478
10Y0.8402.460-1.620
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Integra LifeSciences Holdings Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Integra LifeSciences Holdings Corporation assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Integra LifeSciences Holdings Corporation to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.62 means that Integra LifeSciences Holdings Corporation assets are financed with 61.7% credit (debt) and the remaining percentage (100% - 61.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 0.617. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.619. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.617TTM0.619-0.001
TTM0.619YOY0.566+0.052
TTM0.6195Y0.581+0.038
5Y0.58110Y0.586-0.005
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6170.404+0.213
TTM0.6190.403+0.216
YOY0.5660.381+0.185
3Y0.5780.395+0.183
5Y0.5810.435+0.146
10Y0.5860.456+0.130
4.5.4.2. Debt to Equity Ratio

Measures if Integra LifeSciences Holdings Corporation is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Integra LifeSciences Holdings Corporation to the Medical Devices industry mean.
  • A Debt to Equity ratio of 161.3% means that company has €1.61 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Integra LifeSciences Holdings Corporation:

  • The MRQ is 1.613. The company is just able to pay all its debts with equity.
  • The TTM is 1.623. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.613TTM1.623-0.010
TTM1.623YOY1.307+0.316
TTM1.6235Y1.396+0.227
5Y1.39610Y1.436-0.040
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6130.554+1.059
TTM1.6230.616+1.007
YOY1.3070.591+0.716
3Y1.3850.634+0.751
5Y1.3960.647+0.749
10Y1.4360.726+0.710
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Integra LifeSciences Holdings Corporation generates.

  • Above 15 is considered overpriced but always compare Integra LifeSciences Holdings Corporation to the Medical Devices industry mean.
  • A PE ratio of 23.66 means the investor is paying €23.66 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Integra LifeSciences Holdings Corporation:

  • The EOD is 12.499. Based on the earnings, the company is underpriced. +1
  • The MRQ is 23.659. Based on the earnings, the company is fair priced.
  • The TTM is -67.826. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD12.499MRQ23.659-11.160
MRQ23.659TTM-67.826+91.486
TTM-67.826YOY84.531-152.357
TTM-67.8265Y-109.801+41.974
5Y-109.80110Y-35.363-74.438
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD12.499-1.143+13.642
MRQ23.659-1.397+25.056
TTM-67.826-1.526-66.300
YOY84.531-1.973+86.504
3Y15.029-2.029+17.058
5Y-109.801-2.238-107.563
10Y-35.363-1.260-34.103
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Integra LifeSciences Holdings Corporation:

  • The EOD is 21.715. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 41.103. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 619.734. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD21.715MRQ41.103-19.388
MRQ41.103TTM619.734-578.631
TTM619.734YOY49.127+570.608
TTM619.7345Y80.437+539.298
5Y80.43710Y48.750+31.687
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD21.715-0.998+22.713
MRQ41.103-1.082+42.185
TTM619.734-1.707+621.441
YOY49.127-4.381+53.508
3Y231.450-3.071+234.521
5Y80.437-3.143+83.580
10Y48.750-3.094+51.844
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Integra LifeSciences Holdings Corporation is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.19 means the investor is paying €1.19 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Integra LifeSciences Holdings Corporation:

  • The EOD is 0.629. Based on the equity, the company is cheap. +2
  • The MRQ is 1.190. Based on the equity, the company is underpriced. +1
  • The TTM is 1.348. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.629MRQ1.190-0.561
MRQ1.190TTM1.348-0.157
TTM1.348YOY2.271-0.924
TTM1.3485Y2.589-1.242
5Y2.58910Y3.117-0.527
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.6291.841-1.212
MRQ1.1902.271-1.081
TTM1.3482.415-1.067
YOY2.2712.996-0.725
3Y2.1683.189-1.021
5Y2.5894.125-1.536
10Y3.1174.339-1.222
4.6.2. Total Gains per Share

2.4. Latest News of Integra LifeSciences Holdings Corporation

Does Integra LifeSciences Holdings Corporation still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Integra LifeSciences Holdings Corporation to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-04-18
22:30
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025Read
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,037,424
Total Liabilities2,492,144
Total Stockholder Equity1,545,280
 As reported
Total Liabilities 2,492,144
Total Stockholder Equity+ 1,545,280
Total Assets = 4,037,424

Assets

Total Assets4,037,424
Total Current Assets1,081,681
Long-term Assets2,955,743
Total Current Assets
Cash And Cash Equivalents 246,375
Short-term Investments 27,192
Net Receivables 272,370
Inventory 429,090
Other Current Assets 29,653
Total Current Assets  (as reported)1,081,681
Total Current Assets  (calculated)1,004,680
+/- 77,001
Long-term Assets
Property Plant Equipment 549,765
Goodwill 1,096,952
Intangible Assets 1,207,588
Long-term Assets Other 66,515
Long-term Assets  (as reported)2,955,743
Long-term Assets  (calculated)2,920,820
+/- 34,923

Liabilities & Shareholders' Equity

Total Current Liabilities922,126
Long-term Liabilities1,570,018
Total Stockholder Equity1,545,280
Total Current Liabilities
Short Long Term Debt 607,076
Accounts payable 82,502
Total Current Liabilities  (as reported)922,126
Total Current Liabilities  (calculated)689,578
+/- 232,548
Long-term Liabilities
Long term Debt 1,196,017
Capital Lease Obligations Min Short Term Debt181,470
Long-term Liabilities Other 146,238
Long-term Liabilities  (as reported)1,570,018
Long-term Liabilities  (calculated)1,523,725
+/- 46,293
Total Stockholder Equity
Retained Earnings 939,915
Total Stockholder Equity (as reported)1,545,280
Total Stockholder Equity (calculated)939,915
+/- 605,365
Other
Capital Stock916
Common Stock Shares Outstanding 77,164
Net Debt 1,556,718
Net Invested Capital 3,348,373
Net Working Capital 159,555
Property Plant and Equipment Gross 946,688



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
1,807,954
2,049,015
2,101,131
2,418,187
3,211,257
3,247,693
3,185,773
3,178,642
3,107,887
3,205,711
3,290,410
3,346,580
3,303,240
3,447,565
3,391,759
3,453,521
3,615,136
3,741,554
3,712,787
3,774,465
3,782,383
3,671,997
3,752,862
3,807,013
3,889,758
3,742,399
3,777,601
3,739,371
3,781,988
4,078,224
4,074,495
4,065,803
4,037,424
4,037,4244,065,8034,074,4954,078,2243,781,9883,739,3713,777,6013,742,3993,889,7583,807,0133,752,8623,671,9973,782,3833,774,4653,712,7873,741,5543,615,1363,453,5213,391,7593,447,5653,303,2403,346,5803,290,4103,205,7113,107,8873,178,6423,185,7733,247,6933,211,2572,418,1872,101,1312,049,0151,807,954
   > Total Current Assets 
495,170
568,919
616,166
944,943
822,146
848,650
821,322
827,983
775,082
822,686
868,672
883,813
858,168
1,008,672
966,222
1,152,096
1,237,202
1,039,075
1,032,382
1,103,785
1,153,716
1,066,053
1,137,414
1,196,453
1,161,498
1,029,482
1,051,260
1,027,229
1,058,036
1,415,650
1,112,286
1,099,522
1,081,681
1,081,6811,099,5221,112,2861,415,6501,058,0361,027,2291,051,2601,029,4821,161,4981,196,4531,137,4141,066,0531,153,7161,103,7851,032,3821,039,0751,237,2021,152,096966,2221,008,672858,168883,813868,672822,686775,082827,983821,322848,650822,146944,943616,166568,919495,170
       Cash And Cash Equivalents 
102,055
124,113
154,600
481,943
174,935
189,396
183,771
205,991
138,838
157,025
176,084
207,981
198,911
357,712
360,981
396,279
470,166
408,976
397,414
470,231
513,448
407,092
447,152
511,937
456,661
307,367
309,192
273,732
276,402
591,906
215,236
215,157
246,375
246,375215,157215,236591,906276,402273,732309,192307,367456,661511,937447,152407,092513,448470,231397,414408,976470,166396,279360,981357,712198,911207,981176,084157,025138,838205,991183,771189,396174,935481,943154,600124,113102,055
       Short-term Investments 
0
11,286
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,694
71,194
81,691
62,441
27,192
27,19262,44181,69171,19432,6940000000000000000000000000011,2860
       Net Receivables 
148,186
158,234
171,323
171,126
251,799
277,116
263,236
251,806
269,289
279,072
296,507
281,119
283,976
253,490
186,545
224,837
234,212
230,041
237,775
230,610
243,243
246,227
247,929
254,549
273,587
264,065
258,663
256,270
259,327
241,092
271,155
248,298
272,370
272,370248,298271,155241,092259,327256,270258,663264,065273,587254,549247,929246,227243,243230,610237,775230,041234,212224,837186,545253,490283,976281,119296,507279,072269,289251,806263,236277,116251,799171,126171,323158,234148,186
       Inventory 
217,263
239,809
234,680
232,340
296,332
290,474
290,517
290,846
280,347
286,962
296,505
302,622
316,054
338,082
358,756
307,839
310,117
328,049
323,618
327,167
317,386
328,005
320,208
311,060
324,583
351,275
354,293
366,251
389,608
403,422
421,775
436,930
429,090
429,090436,930421,775403,422389,608366,251354,293351,275324,583311,060320,208328,005317,386327,167323,618328,049310,117307,839358,756338,082316,054302,622296,505286,962280,347290,846290,517290,474296,332232,340234,680239,809217,263
       Other Current Assets 
27,666
35,477
10,984
11,701
9,757
7,652
7,691
7,603
16,503
15,759
15,847
16,005
12,984
14,429
14,725
174,002
175,025
15,292
14,551
17,332
13,820
14,942
49,419
31,556
29,150
20,081
129,112
130,976
32,643
35,369
28,790
50,370
29,653
29,65350,37028,79035,36932,643130,976129,11220,08129,15031,55649,41914,94213,82017,33214,55115,292175,025174,00214,72514,42912,98416,00515,84715,75916,5037,6037,6917,6529,75711,70110,98435,47727,666
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
2,383,025
2,421,738
2,462,767
2,445,072
2,438,893
2,425,537
2,301,425
2,377,934
2,702,479
2,680,405
2,670,680
2,628,667
2,605,944
2,615,448
2,610,560
2,728,260
2,712,917
2,726,341
2,712,142
2,723,952
2,662,574
2,962,209
2,966,281
2,955,743
2,955,7432,966,2812,962,2092,662,5742,723,9522,712,1422,726,3412,712,9172,728,2602,610,5602,615,4482,605,9442,628,6672,670,6802,680,4052,702,4792,377,9342,301,4252,425,5372,438,8932,445,0722,462,7672,421,7382,383,025000000000
       Property Plant Equipment 
222,369
229,110
232,074
232,241
269,251
274,029
277,025
287,000
300,112
371,349
414,228
417,122
431,934
431,793
427,714
379,355
371,164
387,367
384,933
381,521
396,246
390,853
447,558
448,999
459,586
461,689
466,222
475,478
496,383
497,190
521,042
537,248
549,765
549,765537,248521,042497,190496,383475,478466,222461,689459,586448,999447,558390,853396,246381,521384,933387,367371,164379,355427,714431,793431,934417,122414,228371,349300,112287,000277,025274,029269,251232,241232,074229,110222,369
       Goodwill 
510,571
578,229
585,410
587,943
937,905
944,495
927,148
926,369
926,475
922,508
926,732
945,282
954,280
951,554
956,207
919,556
932,367
1,010,072
1,015,638
1,012,081
1,013,458
1,008,928
990,406
977,860
1,038,881
1,041,606
1,043,273
1,036,146
1,055,462
1,040,235
1,104,640
1,116,535
1,096,952
1,096,9521,116,5351,104,6401,040,2351,055,4621,036,1461,043,2731,041,6061,038,881977,860990,4061,008,9281,013,4581,012,0811,015,6381,010,072932,367919,556956,207951,554954,280945,282926,732922,508926,475926,369927,148944,495937,905587,943585,410578,229510,571
       Long Term Investments 
0
0
1,293
1,654
2,491
13,647
17,527
20,246
5,350
346
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000003465,35020,24617,52713,6472,4911,6541,29300
       Intangible Assets 
561,175
654,408
648,744
634,052
1,159,627
1,147,954
1,121,845
1,097,259
1,079,496
1,058,630
1,041,620
1,040,350
1,031,591
1,014,227
998,686
973,685
989,436
1,193,681
1,178,884
1,155,795
1,145,573
1,121,971
1,082,275
1,054,035
1,126,609
1,108,759
1,093,596
1,067,023
1,067,833
1,022,609
1,219,942
1,209,548
1,207,588
1,207,5881,209,5481,219,9421,022,6091,067,8331,067,0231,093,5961,108,7591,126,6091,054,0351,082,2751,121,9711,145,5731,155,7951,178,8841,193,681989,436973,685998,6861,014,2271,031,5911,040,3501,041,6201,058,6301,079,4961,097,2591,121,8451,147,9541,159,627634,052648,744654,408561,175
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
79,133
16,720
33,008
14,644
38,989
35,401
20,679
11,277
36,733
20,864
29,486
16,440
29,513
48,227
77,898
57,190
56,183
67,200
77,908
58,194
68,365
70,822
54,014
66,515
66,51554,01470,82268,36558,19477,90867,20056,18357,19077,89848,22729,51316,44029,48620,86436,73311,27720,67935,40138,98914,64433,00816,72079,133000000000
> Total Liabilities 
968,287
1,196,524
1,206,576
1,505,071
2,248,951
2,249,253
1,843,868
1,813,561
1,732,091
1,808,681
1,869,459
1,961,606
1,886,504
2,105,762
2,042,663
2,055,534
2,100,269
2,212,223
2,137,806
2,142,778
2,097,579
2,056,800
2,091,945
2,082,599
2,085,355
2,067,461
2,094,441
2,160,150
2,194,104
2,480,272
2,540,300
2,544,216
2,492,144
2,492,1442,544,2162,540,3002,480,2722,194,1042,160,1502,094,4412,067,4612,085,3552,082,5992,091,9452,056,8002,097,5792,142,7782,137,8062,212,2232,100,2692,055,5342,042,6632,105,7621,886,5041,961,6061,869,4591,808,6811,732,0911,813,5611,843,8682,249,2532,248,9511,505,0711,206,5761,196,524968,287
   > Total Current Liabilities 
123,601
188,083
177,877
210,234
348,911
336,020
233,342
258,340
262,552
288,106
315,111
302,641
331,309
246,485
212,415
255,146
401,013
412,301
318,756
332,858
340,021
315,833
295,596
304,452
320,906
282,293
377,496
355,712
306,980
302,394
328,316
912,563
922,126
922,126912,563328,316302,394306,980355,712377,496282,293320,906304,452295,596315,833340,021332,858318,756412,301401,013255,146212,415246,485331,309302,641315,111288,106262,552258,340233,342336,020348,911210,234177,877188,083123,601
       Short-term Debt 
0
6,250
881,018
19,934
61,845
60,451
1,476,488
11,250
22,500
33,750
45,000
45,000
45,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000045,00045,00045,00033,75022,50011,2501,476,48860,45161,84519,934881,0186,2500
       Short Long Term Debt 
0
6,250
881,018
19,934
61,845
60,451
1,476,488
11,250
22,500
33,750
45,000
45,000
45,000
0
11,250
22,500
146,250
155,900
45,000
45,000
45,000
45,000
50,625
56,250
38,125
0
95,644
85,387
14,531
19,375
24,219
601,505
607,076
607,076601,50524,21919,37514,53185,38795,644038,12556,25050,62545,00045,00045,00045,000155,900146,25022,50011,250045,00045,00045,00033,75022,50011,2501,476,48860,45161,84519,934881,0186,2500
       Accounts payable 
116,789
136,699
42,193
40,740
93,967
86,995
84,037
86,380
76,050
100,553
107,191
94,158
113,090
97,061
58,291
50,254
54,608
61,500
65,512
59,600
61,837
88,371
69,498
80,732
102,100
112,785
99,766
93,550
92,326
94,397
107,492
77,666
82,502
82,50277,666107,49294,39792,32693,55099,766112,785102,10080,73269,49888,37161,83759,60065,51261,50054,60850,25458,29197,061113,09094,158107,191100,55376,05086,38084,03786,99593,96740,74042,193136,699116,789
       Other Current Liabilities 
6,812
45,134
20,211
35,083
59,278
53,006
13,603
8,903
7,759
7,550
3,507
3,984
14,673
9,834
10,107
23,689
26,645
23,465
36,994
39,094
31,378
41,016
26,984
23,729
18,581
34,323
0
0
0
0
0
0
0
000000034,32318,58123,72926,98441,01631,37839,09436,99423,46526,64523,68910,1079,83414,6733,9843,5077,5507,7598,90313,60353,00659,27835,08320,21145,1346,812
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
1,520,575
1,554,348
1,658,965
1,555,195
1,859,277
1,830,248
1,800,388
1,699,256
1,799,922
1,819,050
1,809,920
1,757,558
1,740,967
1,796,349
1,778,147
1,764,449
1,785,168
1,716,945
1,804,438
1,887,124
2,177,878
2,211,984
1,631,653
1,570,018
1,570,0181,631,6532,211,9842,177,8781,887,1241,804,4381,716,9451,785,1681,764,4491,778,1471,796,3491,740,9671,757,5581,809,9201,819,0501,799,9221,699,2561,800,3881,830,2481,859,2771,555,1951,658,9651,554,3481,520,575000000000
       Capital Lease Obligations Min Short Term Debt
0
-6,250
-881,018
-19,934
-61,845
-60,451
-1,476,488
-11,250
-22,500
-33,750
62,645
63,655
64,757
113,292
111,984
101,296
100,936
109,449
109,183
108,366
105,104
102,106
166,772
171,021
172,044
171,702
174,156
182,478
182,133
186,385
184,174
182,847
181,470
181,470182,847184,174186,385182,133182,478174,156171,702172,044171,021166,772102,106105,104108,366109,183109,449100,936101,296111,984113,29264,75763,65562,645-33,750-22,500-11,250-1,476,488-60,451-61,845-19,934-881,018-6,2500
       Other Liabilities 
30,745
28,855
160,799
142,204
117,323
141,206
134,038
134,220
128,441
108,167
112,804
126,218
116,108
106,299
110,968
127,254
131,181
172,744
178,527
175,430
135,903
144,818
142,296
133,472
201,839
187,466
0
0
0
0
0
0
0
0000000187,466201,839133,472142,296144,818135,903175,430178,527172,744131,181127,254110,968106,299116,108126,218112,804108,167128,441134,220134,038141,206117,323142,204160,79928,85530,745
> Total Stockholder Equity
839,667
852,491
894,555
913,116
962,306
998,440
1,341,905
1,365,081
1,375,796
1,397,030
1,420,951
1,384,974
1,416,736
1,341,803
1,349,096
1,397,987
1,514,867
1,529,331
1,574,981
1,631,687
1,684,804
1,615,197
1,660,917
1,724,414
1,804,403
1,674,938
1,683,160
1,579,221
1,587,884
1,597,952
1,534,195
1,521,587
1,545,280
1,545,2801,521,5871,534,1951,597,9521,587,8841,579,2211,683,1601,674,9381,804,4031,724,4141,660,9171,615,1971,684,8041,631,6871,574,9811,529,3311,514,8671,397,9871,349,0961,341,8031,416,7361,384,9741,420,9511,397,0301,375,7961,365,0811,341,905998,440962,306913,116894,555852,491839,667
   Common Stock
777
782
804
813
813
817
877
880
880
882
883
886
887
889
892
892
893
894
895
896
896
900
903
903
905
908
0
0
0
0
0
0
0
0000000908905903903900896896895894893892892889887886883882880880877817813813804782777
   Retained Earnings 
220,443
226,837
237,673
240,831
285,186
297,500
309,941
323,236
348,373
381,129
410,865
383,255
398,574
407,553
407,184
439,521
532,265
574,888
609,955
653,184
698,568
731,469
776,257
826,172
879,118
903,344
907,528
927,025
946,859
943,578
931,176
920,481
939,915
939,915920,481931,176943,578946,859927,025907,528903,344879,118826,172776,257731,469698,568653,184609,955574,888532,265439,521407,184407,553398,574383,255410,865381,129348,373323,236309,941297,500285,186240,831237,673226,837220,443
   Accumulated Other Comprehensive Income 000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,610,527
Cost of Revenue-728,466
Gross Profit882,061882,061
 
Operating Income (+$)
Gross Profit882,061
Operating Expense-1,582,116
Operating Income28,411-700,055
 
Operating Expense (+$)
Research Development115,377
Selling General Administrative716,983
Selling And Marketing Expenses-
Operating Expense1,582,116832,360
 
Net Interest Income (+$)
Interest Income20,040
Interest Expense-70,632
Other Finance Cost-0
Net Interest Income-50,592
 
Pretax Income (+$)
Operating Income28,411
Net Interest Income-50,592
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-18,23724,467
EBIT - interestExpense = -70,632
-6,944
63,688
Interest Expense70,632
Earnings Before Interest and Taxes (EBIT)-52,395
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-18,237
Tax Provision--11,293
Net Income From Continuing Ops-6,944-6,944
Net Income-6,944
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net3,94450,592
 

Technical Analysis of Integra LifeSciences Holdings Corporation
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Integra LifeSciences Holdings Corporation. The general trend of Integra LifeSciences Holdings Corporation is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Integra LifeSciences Holdings Corporation's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Integra LifeSciences Holdings Corporation Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Integra LifeSciences Holdings Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.10 < 15.30 < 20.20.

The bearish price targets are: .

Know someone who trades $IL3? Share this with them.👇

Integra LifeSciences Holdings Corporation Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Integra LifeSciences Holdings Corporation. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Integra LifeSciences Holdings Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Integra LifeSciences Holdings Corporation. The current macd is -1.67021924.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Integra LifeSciences Holdings Corporation price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Integra LifeSciences Holdings Corporation. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Integra LifeSciences Holdings Corporation price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Integra LifeSciences Holdings Corporation Daily Moving Average Convergence/Divergence (MACD) ChartIntegra LifeSciences Holdings Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Integra LifeSciences Holdings Corporation. The current adx is 32.77.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Integra LifeSciences Holdings Corporation shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Integra LifeSciences Holdings Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Integra LifeSciences Holdings Corporation. The current sar is 15.02.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Integra LifeSciences Holdings Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Integra LifeSciences Holdings Corporation. The current rsi is 26.32. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Integra LifeSciences Holdings Corporation Daily Relative Strength Index (RSI) ChartIntegra LifeSciences Holdings Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Integra LifeSciences Holdings Corporation. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Integra LifeSciences Holdings Corporation price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Integra LifeSciences Holdings Corporation Daily Stochastic Oscillator ChartIntegra LifeSciences Holdings Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Integra LifeSciences Holdings Corporation. The current cci is -199.16081187.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Integra LifeSciences Holdings Corporation Daily Commodity Channel Index (CCI) ChartIntegra LifeSciences Holdings Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Integra LifeSciences Holdings Corporation. The current cmo is -52.47744716.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Integra LifeSciences Holdings Corporation Daily Chande Momentum Oscillator (CMO) ChartIntegra LifeSciences Holdings Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Integra LifeSciences Holdings Corporation. The current willr is -97.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Integra LifeSciences Holdings Corporation Daily Williams %R ChartIntegra LifeSciences Holdings Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Integra LifeSciences Holdings Corporation.

Integra LifeSciences Holdings Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Integra LifeSciences Holdings Corporation. The current atr is 0.72303433.

Integra LifeSciences Holdings Corporation Daily Average True Range (ATR) ChartIntegra LifeSciences Holdings Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Integra LifeSciences Holdings Corporation. The current obv is -3,490.

Integra LifeSciences Holdings Corporation Daily On-Balance Volume (OBV) ChartIntegra LifeSciences Holdings Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Integra LifeSciences Holdings Corporation. The current mfi is 39.97.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Integra LifeSciences Holdings Corporation Daily Money Flow Index (MFI) ChartIntegra LifeSciences Holdings Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Integra LifeSciences Holdings Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-18 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-19 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-20 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-27 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-02 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-03 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-08 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-14 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-15 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-16 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-17 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-20 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-23 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-06 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-07 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06 00:00:00MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-12 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-13 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-18 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-25 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-26 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-04 00:00:00BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-08 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-16 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-24 00:00:00RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-25 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-29 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-05 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Integra LifeSciences Holdings Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Integra LifeSciences Holdings Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.317
Ma 20Greater thanMa 5014.610
Ma 50Greater thanMa 10018.272
Ma 100Greater thanMa 20020.598
OpenGreater thanClose11.200
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Integra LifeSciences Holdings Corporation with someone you think should read this too:
  • Are you bullish or bearish on Integra LifeSciences Holdings Corporation? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Integra LifeSciences Holdings Corporation? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Integra LifeSciences Holdings Corporation

I send you an email if I find something interesting about Integra LifeSciences Holdings Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Integra LifeSciences Holdings Corporation.

Receive notifications about Integra LifeSciences Holdings Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.